Lingfeng Zeng

Guangzhou University of Chinese Medicine — China

Medicine · Health Sciences

11h-index586citations35works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Kidney Disease and Diabetes(6), Renal Diseases and Glomerulopathies(5), Mitochondrial Function and Pathology(4), Diabetes Treatment and Management(4), Bone health and osteoporosis research(2)

Publications35 total

Multimodal MRI reveals hypothalamic structural-functional alterations associated with bone mineral density loss in postmenopausal women
Brain Imaging and Behavior·2026
Research Progress on the Intervention of Traditional Chinese Medicine Monomers on Signaling Pathways Related to Sarcopenia and Osteoporosis
Current Protein and Peptide Science·2026
RETRACTED: Application of artificial intelligence-assisted Traditional Chinese medicine formula granules in bone and joint degenerative diseases in the field of holistic health
Frontiers in Medicine·2025· 1 citedOpen Access
The Impact of Diabetes Mellitus on the Osseointegration of Ab-sorbable Screws: An Animal Experimental Investigation
Sains Malaysiana·2025Open Access
Research progress of Sinomenium in the treatment of rheumatoid arthritis and suggestions for future research
Allergologia et Immunopathologia·2025· 3 citedOpen Access
Estrogen Receptor Alpha–Expressing Neurons in Bed Nucleus of the Stria Terminalis and Hypothalamus Encoding Aggression and Mating
eNeuro·2024Open Access
AI-Safe-C score: Assessing liver-related event risks in patients without cirrhosis after successful direct-acting antiviral treatment
Journal of Hepatology·2024· 10 cited
Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease
BMC Nephrology·2024· 6 citedOpen Access
Image Monitoring System Based on Deep Neural Network
2023
FUDNC1 ameliorates doxorubicin-induced cardiotoxicity by restoring MERCs structure and blocked autophagic flux
European Heart Journal·2023· 1 citedOpen Access
The effect of Dipeptidyl peptidase 4 (DPP-4) inhibitors on hemoglobin level in diabetic kidney disease: A retrospective cohort study
Medicine·2023· 2 citedOpen Access
Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease
Kidney & Blood Pressure Research·2023· 4 citedOpen Access
Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study
Kidney Medicine·2022· 19 citedOpen Access
Feature Genes in Neuroblastoma Distinguishing High-Risk and Non-high-Risk Neuroblastoma Patients: Development and Validation Combining Random Forest With Artificial Neural Network
Frontiers in Medicine·2022· 3 citedOpen Access
An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
Evidence-based Complementary and Alternative Medicine·2022· 4 citedOpen Access
POS-356 DPP-4 inhibitor reduces the worsening of anemia in diabetic kidney disease
Kidney International Reports·2022Open Access
Differential Diagnosis of Hemophagocytic Syndrome by 18F-FDG PET/CT: A Meta-Analysis
Journal of Healthcare Engineering·2022· 2 citedOpen Access
[Renal sympathetic denervation can significantly reduce blood pressure and improve arterial stiffness in hypertensive beagles].
PubMed·2021· 2 citedOpen Access
Urinary podocyte markers in kidney diseases
Clinica Chimica Acta·2021· 33 cited
Urinary Glycogen Synthase Kinase 3β Level Predicts the Progression of Hypertensive Nephrosclerosis
Journal of the American Society of Nephrology·2021
page 1 of 2Next →

Frequent Co-authors

Ming Yang(7), Lin Sun(7), Cheuk‐Chun Szeto(7), Na Jiang(5), Shan Xiong(5), Ying Xiao(5), Gordon Chun‐Kau Chan(5), Jack Kit‐Chung Ng(5), Yachun Han(4), Ling Wei(4), Chenrui Li(4), Winston Wing‐Shing Fung(4), Huapeng Lin(4), Hao Zhao(3), Xiaofen Xiong(3), Peng Gao(3), Shikun Yang(3), Jinfei Yang(3), Kai Ming Chow(3), Zhuoxu Gu(3)